BEVERLY HILLS, CA / ACCESS Newswire / July 18, 2025 / World-renowned spinal neurosurgeon and motion preservation expert Dr.

The field of gerontology is witnessing a significant demographic transition, as the global population of individuals aged 65 ...

Degenerative disc disease (DDD) and intervertebral disc degeneration (IVDD) represent conditions that impair the function of the spinal motion segments, profoundly affecting quality of life worldwide.

Emerging Degenerative Disc Disease therapies in the different phases of clinical trials are-SB-01, BRTX-100, Rexlemestrocel-L, Lorecivivint, CWT 002, AMG0103, IDCT, KUR 113, BRTX-100, AGA111, and ...

Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced that the United ...

According to Credence Research, the global Spine Degenerative Disk Disease Treatment Market was valued at USD 22,272.2 ...

Rochester Institute of Technology researchers are improving non-invasive treatment options for degenerative disc disease, an ailment that impacts 3 million adults yearly in the U.S., according to the ...

Lewy body disease is the second most common brain degenerative disease after Alzheimer's disease. Lewy bodies, deposits of alpha-synuclein protein, are found in the brainstem, limbic system and ...